Johnson & Johnson (JNJ) Company Profile:
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. Its Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads under the STAYFREE and CAREFREE brands, and tampons under the o.b. brand; wound care products comprising adhesive bandages under the BAND-AID brand and first aid products under the NEOSPORIN brand. The company's Pharmaceutical segment offers various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, cardiovascular and metabolic, and pulmonary hypertension diseases. Its Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; diabetes care products that include blood glucose monitoring; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Price: 122,41 Mean Analyst Target Price: 145,1
Market cap.: 328.33Billion| Sector: Healthcare | Industry: Drug Manufacturers - Major
Sales: 78.69Billion | Income: 14.85Billion
1-Year Price Range: 118.62 - 148.32 | 1-Y Performance: -7.8% | YTD Performance: -12.4%
Yield: 2.94% | P/E: 22,58 | Fwd. P/E 14,27 | P/S: 4,17 | P/B: 5,19
Key Ratios:
Growth
Sales Growth Q/Q
12.60%
|
EPS Growth
Q/Q
-0.40%
|
EPS Growth This Year
-8.50%
|
EPS Growth Next Year
5.63%
|
EPS Growth Next 5
Years
7.79%
|
Sales Growth Past 5
Years
2.60%
|
EPS Growth Past 5
Years
7.10%
|
Returns, Margin and Leverage
Return on Assets
0.80%
|
Return on Equity
1.80%
|
Gross Margin
66.30%
|
ROI
15.70%
|
Operating Margin
22.30%
|
Profit Margin
1.60%
|
Debt-to-Equity Ratio
0,51
|
Per Share Data
Price
122,41
|
Analyst Target price
145,1
|
Cash per Share
5,67
|
Book Value Per share
23,58
|
EPS TTM
5,42
|
EPS Next Year
8,58
|
Dividend
Payout
616.60%
|
Valuation
P/E
22,58
|
Forward
P/E
14,27
|
Price to Sales
4,17
|
Price to Book
5,19
|
PEG
2,9
|
Beta
0,74
|
RSI
44,47
|
5-Year Stock Dividend Chart
10-Year Stock Return Heatmap
If you want to receive the full Corporate Factbook of Johnson & Johnson with all fresh updated content tables, just make a small donation of just 9 USD.
After we’ve received the donation, we will send you the full PDF to your donation e-mail address.
This update is created for you exclusively. If you like to join the lifetime e-mail list of the latest Corporate Factbook updates, just use the general link here. You can decide how much you like to support us.
Thank you so much for supporting us.
Here is an example of the fresh updated Corporate Factbook you will receive: